Cameron Lionel Groome Sells 200,000 Shares of Microbix Biosystems Inc. (TSE:MBX) Stock

Microbix Biosystems Inc. (TSE:MBX - Get Free Report) Director Cameron Lionel Groome sold 200,000 shares of the firm's stock in a transaction that occurred on Wednesday, January 22nd. The stock was sold at an average price of C$0.43, for a total value of C$86,500.00.

Microbix Biosystems Trading Down 2.0 %

MBX traded down C$0.01 during trading on Friday, hitting C$0.49. 145,336 shares of the stock were exchanged, compared to its average volume of 307,747. The company has a debt-to-equity ratio of 22.68, a quick ratio of 5.57 and a current ratio of 6.62. The firm has a 50 day simple moving average of C$0.38 and a 200 day simple moving average of C$0.35. The firm has a market cap of C$66.98 million, a price-to-earnings ratio of 12.25 and a beta of 0.34. Microbix Biosystems Inc. has a 1 year low of C$0.29 and a 1 year high of C$0.52.

About Microbix Biosystems

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.